Abiomed
ABMD
#1101
Rank
NZ$29.97 B
Marketcap
$664.84
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

EPS for Abiomed (ABMD)

EPS in 2022 (TTM): $9.39

According to Abiomed's latest financial reports the company's current EPS (TTM) is $10.26. In 2021 the company made an earnings per share (EPS) of $5.11 a decrease over its 2020 EPS that were of $7.76.

EPS history for Abiomed from 2013 to 2022

Annual EPS

Year EPS Change
2022 (TTM)$9.3983.65%
2021$5.11-34.16%
2020$7.76-18.05%
2019$9.479.48%
2018$8.65141.95%
2017$3.5881.42%
2016$1.97-62.83%
2015$5.30575.56%
2014$0.79125%
2013$0.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$15.01 46.26%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.43-86.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.94-109.18%๐Ÿ‡บ๐Ÿ‡ธ USA